Clinical Trial Update: Study of BMS-986315 Alone and in Combination With Nivolumab or Cetuximab in Participants With Advanced Solid Tumors [Phase 1, Phase 2]

View source ↗

Summary

This update reports the completion of a Phase 1/2 trial evaluating BMS-986315 alone and in combination with nivolumab or cetuximab in adults with advanced solid…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumors

Drugs mentioned

• BMS-986315
• Cetuximab (cetuximab)
• nivolumab (nivolumab)

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Advanced Solid Tumor | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2025-12-17